Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Womens Imaging: Page 162
RT linked to hypothyroidism after breast cancer
By
AuntMinnieEurope.com staff writers
Norwegian women who were treated with radiation therapy for stage II/III breast cancer had rates of thyroid disease as much as 300% higher than normal controls, according to a study published in the November issue of the
International Journal of Radiation Oncology, Biology, Physics
.
October 20, 2009
Siemens launches breast tomo in Europe
By
AuntMinnieEurope.com staff writers
Siemens Healthcare has begun commercial shipments in Europe of a full-field digital mammography system with 3D digital breast tomosynthesis capability.
October 19, 2009
Study: Lung scintigraphy tops CTA in PE
By
AuntMinnieEurope.com staff writers
Lung scintigraphy may be more reliable than pulmonary CT angiography (CTA) for identifying or excluding pulmonary embolism (PE) in pregnant patients, according to a study published in the November issue of the
American Journal of Roentgenology
.
October 19, 2009
Premature delivery common after cancer diagnosis
By
Reuters Health
NEW YORK (Reuters Health), Oct 20 - Iatrogenic preterm delivery is common among women diagnosed with invasive cancer during pregnancy, a new multicenter study shows. The study, published online in the
Journal of Clinical Oncology
, involved 215 women who received diagnoses of invasive cancers during pregnancy between 1998 and 2008.
October 19, 2009
Carestream nets U.K. contract
By
AuntMinnieEurope.com staff writers
Carestream Health has been awarded a contract to supply its Carestream PACS software with diagnostic mammography workstations and integrated RIS to Dorset Breast Screening Unit.
October 18, 2009
Barco upgrades mammo display
By
AuntMinnieEurope.com staff writers
Image display firm Barco has released an upgraded version of its Coronis 5MP Mammo mammography display system.
October 12, 2009
'Spontaneous regression' debate erupts anew at ASCO symposium
By
Kate Madden Yee
SAN FRANCISCO - Is it possible that some breast cancers "spontaneously regress" and would otherwise become harmless if they weren't detected on screening mammography? The controversial theory was the topic of a heated debate at last week's American Society of Clinical Oncology's (ASCO) Breast Cancer Symposium.
October 11, 2009
Dilon lands deal with Philips
By
AuntMinnieEurope.com staff writers
Molecular breast imaging developer Dilon Diagnostics has signed a distribution agreement with Philips Healthcare covering markets in Europe and the Middle East.
October 11, 2009
European x-ray, mammo market going digital
By
AuntMinnieEurope.com staff writers
The European general radiography market now features the near-ubiquitous use of digital systems, and the mammography sector is also well on its way, according to a report by market research firm InMedica.
October 7, 2009
Axillary ultrasound can help avoid sentinel node biopsy surgery
By
Reuters Health
NEW YORK (Reuters Health), Oct 8 - Use of axillary ultrasound combined with fine-needle aspiration cytology can prevent unnecessary sentinel lymph node biopsy in roughly 30% of node-positive, early breast cancer patients, researchers said this week at a press briefing for the 2009 Breast Cancer Symposium in San Francisco.
October 7, 2009
Ultrasound densitometry finds beer helps women keep strong bones
By
Erik L. Ridley
While wine has long been cited for its health benefits, beer hasn't enjoyed nearly the same positive reputation. But a study published in the October issue of
Nutrition
found that ultrasound bone-density values were higher for women who drink beer, besting both wine drinkers and teetotalers.
September 22, 2009
Pentoxifylline/vitamin E combo may prevent some radiation side effects
By
Reuters Health
NEW YORK (Reuters Health), Sep 18 - The combination of pentoxifylline and vitamin E prevented radiation-induced lymphedema among breast cancer patients in a phase II trial in Sweden.
September 17, 2009
Previous Page
Page 162 of 178
Next Page